INTRODUCTION
The elucidation of the mechanisms by which neuropeptides are physiologically inactivated is an important challenge which has inspired a growing number of reports. Some of these studies have led to the detection and the purification of novel peptidases which were shown to hydrolyse a variety of neuropeptides in vitro. However, the determination of the exact role of these enzymes in the modulation of neuropeptide concentrations in vivo often appears difficult due to technical limitations and is always subject to the development of specific tools.
We have previously examined the process of neurotensin inactivation by rat brain synaptic membranes (Checler et al., 1983) . Later, studies on the catabolism of this peptide were extended to membrane or cell preparations containing high-affinity neurotensin receptor sites whose occupancy was directly linked to a modulation of subcellular events (Amar et al., 1985 Bozou et al., 1986) . Although the patterns of neurotensin inactivation varied according to the tissue source (Checler et al., 1988) , in all cases a primary inactivating cleavage occurred at the Pro10-Tyr11 bond, yielding the biologically inactive fragments neurotensin-(1-10) and neurotensin-(1 1-13). The ubiquitous activity responsible for this cleavage appeared insensitive to specific inhibitors developed against other already isolated peptidases (Checler et al., 1984) . This was the first indication of the presence of a novel enzyme, and this finding was later corroborated by the purification and complete biochemical characterization of the peptidase from rat brain (Checler et al., 1986a; Barelli et al., 1988a 
MATERIALS AND METHODS Purification of the peptidase
The peptidase was purified from 100 rat brains according to the procedure previously described (Checler et al., 1986a 
Purification of IgG
The presence of several plasma proteases in the preimmune serum precluded the possibility of examining directly the putative anticatalytic properties of the immune serum. Therefore, the purified IgG fractions from both immune and preimmune sera were obtained after treatment with octanoic acid according to the procedure previously described (Steinbuch & Audran, 1969 of 100 mM-Tris/HCl, pH 7.5, containing 0.02% bovine serum albumin. Neurotensin (2 nmol) was then added and incubations carried out for I h at 37°C, being terminated by acidification (104la of 1.25 M-HCI). Neurotensin hydrolysis was monitored by h.p.l.c. using the conditions previously described (Checler et al., 1988) . Briefly, analyses were performed by means of a 35 min linear gradient of 0.1 % trifluoroacetic acid (TFA), 0.05 % triethylamine (TEA)/0.1 % TFA, 0.05 % TEA in acetonitrile from 90:10 to 65:35 (v/v) (Barelli et al., 1988a) . Elutions were carried out at room temperature at a flow rate of I ml/min and absorbance was monitored at 230 nm.
Immunoprecipitation
Purified peptidase (0.1 ug) was preincubated in the conditions described above with 20,1 of preimmune (8 mg/ml) or immune (10 mg/ml) IgG fractions. Protein A-Sepharose (100 ,l, 100 mg/ml) was added and incubated for 2 h at room temperature under vigorous stirring. Incubations were then centrifuged (10 min, 10000 g) and the supernatants were tested for neurotensin degradation as described above.
Preparation of tissues, cell lines and membranes
Brains and other organs were homogenized by Polytron (setting = 6) for 15 s in 10 vols. of 10 % sucrose in the presence or absence of a mixture of inhibitors comprising EDTA (10 mM), iodoacetamide (1 mM), phenylmethanesulphonyl fluoride (1 mM) and pepstatin
(1 ,M), and then centrifuged for 20 min at 800 g. The supernatants were removed, and centrifuged for 20 min at 3000 g, and the resulting pellets were resuspended with 2 ml of 20 mM-Tris/HCl, pH 7.5, with or without the mixture of inhibitors. Primary cultured neurones, neuroblastoma NI El 15 and HT29 cells were cultured as previously described (Checler et al., 1986b,c) . Cells were spun for 5 min at 800 g then resuspended and homogenized in 5 mM-Tris/ HCl, pH 7.5. Homogenates were centrifuged for 5 min at 1500 g and both supernatant and pellet fractions were kept for further analysis.
The following highly purified membrane preparations were kindly provided by Dr. Jo-Ann Fox (School of Nursing, McMaster University, Hamilton, Canada). Plasma membranes from dog mesenteric arteries and rat fundus were prepared as described (Kwan et al., 1979; 1982) . Plasma membranes from circular and longitudinal dog ileum smooth muscle were purified according to previously reported procedures Kostka et al., 1987) .
SDS/PAGE and Western blot analysis
Aliquots of tissue homogenates were suspended in 100 1l of sodium phosphate buffer, pH 7.5, containing 2 % SDS and 5 % fl-mercaptoethanol. Samples were boiled and electrophoresed overnight (15 mA/gel) according to a classical procedure (Laemmli, 1970) in 8% acrylamide gels. Proteins were then blotted onto nitrocellulose sheets according to the procedure described by Towbin et al. (1979) . Efficiency of the blotting was checked by revealing the transferred proteins with 0.20 Ponceau Red in 3 % trichloroacetic acid. Nitrocellulose was then destained with 140 mM-NaCl/20 mM-Tris/HCl, pH 7.5 (buffer A), containing 0.20% Tween 20, and incubated for 4 h at room temperature in buffer A containing 300 bovine serum albumin. Nitrocellulose was then exposed overnight to a 1:1000 dilution of the preimmune or immune IgG fractions (in buffer A containing 1 % bovine serum albumin). Sheets. were rinsed (5 x 5 min) with buffer A containing 0.2 % Tween 20 then exposed for 3 h to a 1:800 dilution of goat anti-(rabbit immunoglobulins) coupled to peroxidase according to the manufacturer's recommendations (Pharmacia). Nitrocellulose was finally rinsed as above and the IgG-antigen complexes were revealed with 100 ml of methanol/buffer A (1:9, v/v) containing 30 mg of 4-chloro-1-naphthol and addition of 100 ,ul of H202'
RESULTS
The presence in the preimmune serum of several plasma proteases able to hydrolyse neurotensin precluded the possibility of studying the anticatalytic properties of the immune serum. Materials and methods. Protein A-Sepharose (100lul, 100 mg/ml) was added for a further 2 h incubation; the incubation mixtures were then centrifuged (10 min, 10000 g). Supernatants were tested for neurotensin degradation and analysed by h.p.l.c. as described in Materials and methods. Arrows indicate the retention times of neurotensin (NT) synthetic fragments run in the same conditions. preimmune fraction was totally devoid of anticatalytic properties (Fig. 1) . In agreement with this finding, immunoprecipitation experiments clearly established the presence of IgG capable of interacting with the rat brain peptidase in the immune fraction but not in the preimmune fraction (Fig. 2) . Finally, immunoblots of total proteins of rat brain homogenates revealed that only one band was specifically recognized by the immune immunoglobulins and that the position of the stain closely corresponded to that of the purified neurotensindegrading peptidase (Fig. 3) .
The specificity of the immune IgG allowed us to examine the tissue-specificity of the neurotensinhydrolysing activity in the rat. In fact the peptidase was detected in most of the rat peripheral organs except the duodenum (Fig. 4) methods) this latter staining was strongly reduced while the high molecular weight protein was more densely labelled, indicating that the smaller protein probably represented a degradation product generated by proteolytic activities present in the homogenates (results not shown).
The evidence for a ubiquitous localization of the neurotensin-degrading peptidase in tissues from central and peripheral origins was further corroborated by the immunological detection of the enzyme in cell lines from neural and extraneural sources (Fig. 5) . The peptidase was detectable in both the supernatant and pellet fractions obtained from pure primary cultured neurones of mouse embryo cerebral hemispheres as well as in the neuroblastoma clone NI El 15 and was also present in the extraneural cell line A7R5 derived from rat aorta (Fig.  5) . By contrast, no positive immunoreaction was observed when the human colon adenocarcinoma cell line HT29 was examined (Fig. 5) .
Among a series of highly purified membrane preparations of muscular and nervous origin (see Materials Western blot analysis not shown). This was apparently in contradiction with the fact that the neurotensin-degrading peptidase activity was previously detected in plasma membranes from circular and longitudinal dog ileum smooth muscle (Checler et al., 1987) as well as in the nervous layers innervating these tissues (Barelli, H., Checler, F. & Vincent, J.-P., unpublished data). These discrepancies led us to examine the species-specificity of the immune purified IgG fraction. Fig. 6 clearly demonstrates that the immune fraction only stained the enzyme located in the brains of animals belonging to the murine family.
DISCUSSION
The present paper describes the properties of a polyclonal antiserum raised against a recently purified rat brain neurotensin-degrading metallopeptidase and its use to examine the presence of the enzyme in various tissues and membrane preparations.
The IgG-purified fraction obtained from the immune serum precipitated the neurotensin-degrading metallopeptidase and also displayed anticatalytic activity. In addition, immunoblotting experiments revealed that the IgG recognized only one protein present in a rat brain homogenate and that the position of the stain closely corresponded to that of the purified enzyme. None of the above properties was shared by the preimmune fraction. Altogether, this indicated that the IgG-purified fraction could be used as a specific probe to detect the presence of the peptidase.
We recently purified a metallopeptidase from rat ileum that was able to hydrolyse a variety of neuropeptides including neurotensin (Barelli et al., 1988b) . The biochemical characterization of this enzyme indicated that it displayed the same affinity and specificity towards the neurotensin sequence, hydrolysed the same natural peptides and exhibited the same physical characteristics (molecular weight and behaviour on chromatographic supports) as the brain enzyme. Altogether, this indicated that the ileal enzyme probably corresponded to the peripheral counterpart of the brain peptidase. This was confirmed by means of the present purified IgG fraction, which labelled the activity in both an ileum homogenate (Fig. 4) and a purified fraction derived from this tissue (Fig. 7) . The fact that the central and peripheral enzymes appeared to share common antigenic determinants encouraged us to examine the tissue-specificity in the rat. A widespread distribution was observed since all the organs tested except the duodenum contained the peptidase. The catabolism of neurotensin was previously examined in cells from neural origins (Nl El 15 neuroblastoma clone and pure cultured neurons, Checler et al., 1986b,c) . These cell cultures provided interesting models with which to study the physiology of neurotensin since receptor occupancy by the peptide had been shown to modulate various subcellular events including cyclic nucleotide levels and phosphatidylinositol turnover (Amar et al., 1985 . In these cells, a neurotensin(1-10)-generating activity was detected that was ascribed to the neurotensin-degrading metallopeptidase since this cleavage was not inhibited by a series of specific peptidase inhibitors developed against other wellcharacterized cerebral peptidases (Checler et al., 1986a) .
The presence of this enzyme was confirmed by direct immunopositive reaction observed with the immune IgG fraction. Interestingly, the peptidase was recovered in both the supernatant and particulate fractions. This confirmed the biochemical detection of the peptidase in the 100000 g supernatant fraction of a rat brain synaptic membranes homogenate (results not shown) and suggested that the peptidase was partly cytosoluble but could also exist in a membrane-associated form as has already been reported for another metallopeptidase, namely endopeptidase 24.15 (Acker et al., 1987) . The use of the purified IgG fraction appeared to be clearly limited to the detection of the peptidase in tissues or membrane preparations of murine origin (Fig. 6 ). This restricted specificity could explain the discrepancies observed between the biochemical detection of the peptidase in the human adenocarcinoma HT29 cell line (Checler et al., 1 986c) as well as in the circular and longitudinal dog ileum smooth muscle plasma membranes (Checler et al., 1987) , and the total lack of staining obtained after exposure of these preparations to the immune IgG-fraction ( Fig. 5 ; other results not shown).
Since neither specific inhibitor nor fluorimetric substrate have been yet developed against the neurotensin-degrading metallopeptidase, the IgG fraction appears to be the only tool available with which to inhibit or detect the enzyme. These antibodies will also allow us to establish the distribution of The latter possibility together with the fact that the peptidase displays the ability to hydrolyse a variety of biologically active peptides would support a putative general role of the enzyme in the physiological inactivation of neuropeptides.
